Rotational angiography

OrthoGrid Systems and nView medical Partnering to Combine 3D Imaging and Guidance Technology in Musculoskeletal Procedures

Retrieved on: 
Thursday, April 30, 2020
Medicine, Imaging, Imaging science, Optics, Health informatics, Clinical medicine, Computer-assisted surgery, Health, Hybrid operating room, Rotational angiography

Both nView and OrthoGrid technologies are AI-driven, open platforms designed to work within the surgical theater to improve accuracy, workflow efficiency, and patient outcomes.

Key Points: 
  • Both nView and OrthoGrid technologies are AI-driven, open platforms designed to work within the surgical theater to improve accuracy, workflow efficiency, and patient outcomes.
  • With the nView 3D imaging data, planning can be achieved intraoperatively, reducing the need for preoperative planning.
  • "This partnership combines two technological needs within intraoperative imaging: Real-time, 3D imaging, and procedural decision making into one unique solution," said Edouard Saget, Co-Founder and Co-CEO at OrthoGrid.
  • nView develops imaging systems, bringing breakthrough AI solutions for image creation, image processing, and image visualization to surgery.

Structural Heart Devices Market Promises Healthy Growth With a Robust 7.5% CAGR to Reach $13 Bn in 2027

Retrieved on: 
Monday, February 24, 2020
Medical imaging, Rotational angiography, Fields of mathematics, Compound annual growth rate, Market, Academic disciplines, Mathematics

Additionally, the rising geriatric population, and increasing emphasis on private reimbursement models are likely to drive a robust 7.5% CAGR in the structural heart device market.

Key Points: 
  • Additionally, the rising geriatric population, and increasing emphasis on private reimbursement models are likely to drive a robust 7.5% CAGR in the structural heart device market.
  • New innovations in the market are expected to create several opportunities for growth in the structural heart device market.
  • 3D rotational angiography will also emerge as a major avenue for growth for players in the structural heart device market.
  • Collaborations with organizations like these will make way for more opportunities for growth for players in the structural heart devices market.

Global $447M Radiation Dose Management Market Analysis, 2019 to 2024 - Rising Focus on Interventional Radiology & Nuclear Medicine Creates Opportunities

Retrieved on: 
Thursday, August 8, 2019
Medicine, Branches of biology, Radiobiology, Academic disciplines, CT scan, Multidimensional signal processing, Fluoroscopy, Nuclear medicine, Radiation therapy, Medical physics, Rotational angiography

The radiation dose management market is projected to reach USD 447 million by 2024 from USD 206 million in 2019, at a CAGR of 16.7%.

Key Points: 
  • The radiation dose management market is projected to reach USD 447 million by 2024 from USD 206 million in 2019, at a CAGR of 16.7%.
  • On the other hand, the lack of standardized procedures and dose protocols for radiation dose management for healthcare organizations is a major market challenge.
  • Based on product & service, the radiation dose management market is segmented into radiation dose management solutions and radiation dose management services.
  • Based on modality, the radiation dose management market is segmented into computed tomography (CT), fluoroscopy and interventional imaging, mammography, and nuclear medicine.

iSchemaView Launches RAPID™ ANGIO

Retrieved on: 
Thursday, February 28, 2019
Health, Cardiology, Hospitals, Medical devices, Radiology, Projectional radiography, Medicine, Angiography, Siemens Healthineers, Radiology, Rotational angiography, Neuroimaging, Stroke, Health care, Medical specialties

iSchemaView, the worldwide leader in advanced imaging for stroke care and research, today announced RAPID ANGIO, a complete neuroimaging solution for the angiography suite that integrates iSchemaViews RAPID software with syngo DynaCT Multiphase from Siemens Healthineers.

Key Points: 
  • iSchemaView, the worldwide leader in advanced imaging for stroke care and research, today announced RAPID ANGIO, a complete neuroimaging solution for the angiography suite that integrates iSchemaViews RAPID software with syngo DynaCT Multiphase from Siemens Healthineers.
  • This technology, when combined with the RAPID platforms clinically validated CTP product, delivers a powerful imaging solution to the angio suite for acute stroke patients.
  • The RAPID ANGIO module, by combining the best-in-class syngo DynaCT system with the RAPID platform, allows for the direct evaluation of acute stroke patients in the angiography procedure room, saving precious time, said Anil Singhal, MD, SVP, Worldwide Operations at iSchemaView.
  • RAPID ANGIO runs on the RAPID Artificial Intelligence framework.